Department of Neurological Surgery, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
Neurocrit Care. 2010 Apr;12(2):188-98. doi: 10.1007/s12028-010-9330-9.
Critical care management of patients with severe acute brain injury has undergone tremendous advances. Neurosurgeons and neurointensivists have a large armamentarium of invasive monitoring devices available to help detect secondary brain injury and guide therapy. No consensus exists regarding patient specific selection of monitoring devices, the placement of devices in relation to injured brain tissue, or the preferred insertion technique. Here we review our experience in a consecutive series of acutely brain injured patients who underwent multimodality monitoring.
Sixty-one patients admitted to the Neurological Intensive Care Unit underwent multimodality intracranial monitoring between January 2005 and October 2008. Patient demographics, hospital length of stay, types of monitoring devices and modalities monitored, insertion techniques, device placement location relative to injury, and complications are reported.
Monitored modalities included brain tissue oxygen (PbtO(2)) in 97% (N = 59), microdialysis (MD) in 79% (N = 48), intracranial electroencephalography in 31% (N = 19), brain temperature in 18% (N = 11), and cerebral blood flow in 11% (N = 7). On average, monitoring started within 2 days (0-8) of admission and was continued for 7 days (1-17). The majority of probes (56%; N = 35) were placed into patients with focal brain injuries, while in 43% N = 26 the injury was diffuse. Among those with focal injury, probe placement was categorized as peri-lesional in 46% (N = 16), and within a clot or infarct in 17% (N = 6). The most frequent complication of multimodality brain monitoring was device malfunction or dislodgement (43%; N = 26). Rates of hematoma and infection were 3 and 5%, respectively. Average NICU length of stay was 17 days (3-48) and 26% (N = 16) of patients were dead at discharge.
Collaboration among institutions is necessary to establish practice guidelines for the choice and placement of multimodal monitors. Further advancement in device technology is needed to improve insertion techniques, inter-device compatibility, and device durability. Multimodality data needs to be analyzed to determine the preferable device location.
对严重急性脑损伤患者的重症监护管理已经取得了巨大进展。神经外科医生和神经重症医生拥有大量的侵入性监测设备,可帮助发现继发性脑损伤并指导治疗。目前,在患者特定的监测设备选择、设备在受伤脑组织中的放置位置或首选插入技术方面,尚无共识。在这里,我们回顾了在连续一系列急性脑损伤患者中进行多模态监测的经验。
2005 年 1 月至 2008 年 10 月,61 例入住神经重症监护病房的患者接受了多模态颅内监测。报告了患者的人口统计学资料、住院时间、监测的设备和模式类型、插入技术、相对于损伤的设备放置位置以及并发症。
监测的模式包括脑组织氧(PbtO2)97%(N=59)、微透析(MD)79%(N=48)、颅内脑电图 31%(N=19)、脑温 18%(N=11)和脑血流 11%(N=7)。平均而言,监测在入院后 2 天(0-8 天)内开始,持续 7 天(1-17 天)。大多数探头(56%;N=35)被放置在局灶性脑损伤患者中,而 43%(N=26)的损伤为弥漫性。在局灶性损伤患者中,探头放置位置分类为病灶周围 46%(N=16)和血肿或梗死内 17%(N=6)。多模态脑监测最常见的并发症是设备故障或脱位(43%;N=26)。血肿和感染的发生率分别为 3%和 5%。平均 NICU 住院时间为 17 天(3-48 天),出院时 26%(N=16)的患者死亡。
需要机构之间的合作来制定多模态监测选择和放置的实践指南。需要进一步改进设备技术,以提高插入技术、设备间的兼容性和设备耐用性。需要对多模态数据进行分析,以确定理想的设备位置。